Several years prior to the pandemic, a handful of life sciences companies and clinical research organizations began dedicating resources and expertise to better address long-standing challenges in trial design and execution. Placing a premium on innovation, these sponsors and CROs looked at age-old problems in a new way, integrating novel, purpose-driven solutions and gauging how they help resolve specific challenges.
In this webinar, IQVIA experts will share how we determine which solutions are proving to successfully optimize future trials by increasing patient centricity, improving recruitment outcomes with quality in mind and driving site efficiencies.
Denise Messer
Director, Design Analytics, IQVIA Applied Data Science Center
Zoltan Varga
Vice President, Global Head of Patient Recruitment and Enablement
Katie Shaw
Senior Director, Global Patient & Site Solutions
Shawne Moran
Global Head, Strategy and Development, Clinical Trial Educators
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
.svg){kind=icon}
